We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Aurinia Selects Worldwide As CRO For Phase3 Valcosporin Trial

News   Jan 31, 2017 | Original Story From Aurinia Pharmaceuticals

 
Aurinia Selects Worldwide As CRO For Phase3 Valcosporin Trial
 
 
 

RELATED ARTICLES

Shoulder Pain Relief for Wheelchair Users With Spinal Cord Injury

News

Researchers report initial results for a minimally invasive intervention for relief of chronic refractory shoulder pain in upper-limb dependent individuals with spinal cord injury.

READ MORE

Discovery Could Help Treat People With Cardiovascular Disease

News

Researchers have found a link between a peptide called apelin and a reduction of abdominal aortic aneurysms that was shown to dramatically reduce mortality in mice. They are using this knowledge to develop a new medical therapy to treat cardiovascular disease.

READ MORE

Half of Ebola Outbreaks Go Undetected

News

The number of undetected Ebola outbreaks has been estimated, in a study published in PLOS Neglected Tropical Diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE